Evolent Health (FRA:9EH) Construction In Progress: €238 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:9EH Evolent Health Inc FRA:9EH
63 GF Score
Price €5.05
GF Value €9.69
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Evolent Health Construction In Progress?

Evolent Health FRA:9EH +3.06% 63 Construction In Progress is €238 Mil as of Mar. 2026. GuruFocus rates FRA:9EH with a GF Score™ of 63/100 and a GF Value™ of €9.69 (Possible Value Trap). The stock has 7 warning signs investors should review.

Evolent Health's quarterly construction in progress increased from Sep. 2025 (€223 Mil) to Dec. 2025 (€229 Mil) and increased from Dec. 2025 (€229 Mil) to Mar. 2026 (€238 Mil).

Evolent Health's annual construction in progress increased from Dec. 2023 (€195 Mil) to Dec. 2024 (€225 Mil) and increased from Dec. 2024 (€225 Mil) to Dec. 2025 (€229 Mil).

Evolent Health Construction In Progress Historical Data

* Premium members only.

The historical data trend for Evolent Health's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolent Health Construction In Progress Chart

Evolent Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 141.23 178.53 195.24 225.22 228.98

Evolent Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 225.46 219.24 222.72 228.98 237.66
FRA:9EH
63GF Score
Evolent Health Inc FRA:9EH
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolent Health Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of €238 Mil mean?
Evolent Health (FRA:9EH) has a Construction In Progress of €238 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Evolent Health and its competitors.
Is Evolent Health's Construction In Progress too high?
Evolent Health's current Construction In Progress is €238 Mil. Overall, Evolent Health has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Construction In Progress compare to PHR and CTEV?
Evolent Health's Construction In Progress of €238 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Healthcare Providers & Services company?
A good Construction In Progress depends on the Healthcare Providers & Services industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Evolent Health and its competitors. Evolent Health's current Construction In Progress is €238 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (FRA:9EH) is currently considered Possible Value Trap. The stock's GF Value™ is €9.69, compared to a current price of €5.05 — trading 47.9% below its estimated fair value. The current Construction In Progress is €238 Mil. Evolent Health's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Evolent Health (FRA:9EH), the current Construction In Progress is €238 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evolent Health (FRA:9EH) Overvalued in 2026?

Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued. The current stock price of €5.05 is trading 47.9% below its estimated GF Value™ of €9.69. GuruFocus considers Evolent Health to be Possible Value Trap.

Key valuation signals for FRA:9EH:

  • Construction In Progress: €238 Mil
  • GF Value™: €9.69 vs. price of €5.05 (47.9% below fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the FRA:9EH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evolent Health Business Description

Other Exchanges EVH:USA9EH:Germany
Address 1812 North Moore Street, Suite 1705, Arlington, VA, USA, 22209
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
63GF Score

Get the complete analysis for FRA:9EH

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.05
Price
€9.69
GF Value